Skip to main content
. 2000 Dec;11(12):4381–4391. doi: 10.1091/mbc.11.12.4381

Figure 5.

Figure 5

Figure 5

Mapping of novel transcription factor binding element. (A) Sequences of mutated oligonucleotide used for competition in EMSA analysis for mapping the transcription factor binding sites included in oligo-2. (B) F9 nuclear extracts were incubated with 32P-labeled oligonucleotide without or with a 50-fold excess of unlabeled oligo-1 (−177), oligo-2 (32), or the mutated sequences M1–M8 indicated in the figure, or the homologous mouse oligo-2. Arrowheads indicate specific retarded bands.